Jun. 21 at 11:18 PM
$CLRB Not much has been going on in biotech land since some major runs and buyouts the end of last year. One that did go recently was
$QTTB. Impressive results followed by a lady joining their board that could be instrumental in a buyout. Stock went
$1's to
$14.85 with a consensus price target of
$14.25.
CLRB has a consensus target of
$10.33 which coincidentally is just under the street value alone for their Ph 2 candidate that will be reporting great news shortly. Maybe why it's beginning to break out.
